- Home
- GIB vs PODD Comparison
GIB vs PODD Comparison
Compare GIB & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIB
- PODD
- Stock Information
- Founded
- GIB 1976
- PODD 2000
- Country
- GIB Canada
- PODD United States
- Employees
- GIB N/A
- PODD N/A
- Industry
- GIB Professional Services
- PODD Medical/Dental Instruments
- Sector
- GIB Consumer Discretionary
- PODD Health Care
- Exchange
- GIB Nasdaq
- PODD Nasdaq
- Market Cap
- GIB 19.4B
- PODD 22.1B
- IPO Year
- GIB N/A
- PODD 2007
- Fundamental
- Price
- GIB $87.70
- PODD $322.50
- Analyst Decision
- GIB Buy
- PODD Strong Buy
- Analyst Count
- GIB 4
- PODD 19
- Target Price
- GIB $148.25
- PODD $338.79
- AVG Volume (30 Days)
- GIB 310.1K
- PODD 537.2K
- Earning Date
- GIB 11-10-2025
- PODD 11-06-2025
- Dividend Yield
- GIB 0.49%
- PODD N/A
- EPS Growth
- GIB 5.62
- PODD N/A
- EPS
- GIB 5.54
- PODD 3.32
- Revenue
- GIB $11,408,228,844.00
- PODD $2,359,500,000.00
- Revenue This Year
- GIB $11.53
- PODD $29.18
- Revenue Next Year
- GIB $5.16
- PODD $18.16
- P/E Ratio
- GIB $15.33
- PODD $96.58
- Revenue Growth
- GIB 7.13
- PODD 26.00
- 52 Week Low
- GIB $85.90
- PODD $226.50
- 52 Week High
- GIB $122.79
- PODD $353.50
- Technical
- Relative Strength Index (RSI)
- GIB 41.09
- PODD 50.86
- Support Level
- GIB $86.58
- PODD $321.81
- Resistance Level
- GIB $88.41
- PODD $335.26
- Average True Range (ATR)
- GIB 1.43
- PODD 7.22
- MACD
- GIB 0.11
- PODD 1.25
- Stochastic Oscillator
- GIB 35.24
- PODD 49.33
About GIB CGI Inc.
CGI is a Canada-based IT-services provider with an embedded position in North America and Europe. The company generates more than CAD 14 billion in annual revenue, employs over 90,000 personnel, and operates across 400 offices in 40 countries. CGI offers a broad portfolio of services such as consulting, systems integration, application maintenance, and business process services. Its largest vertical market is government, which contributes more than a third of group revenue.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.